CTN :41042605
09 Sep, 2025
45.91 Crore
Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - halothane bp [6], fluorouracil inj ip 250 mg/ 5ml [148], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1 mg [159], digoxin inj ip 0.25 mg/ml [189], hydrogen peroxide solution ip 6 o/o (20 vol) [248], clomifene tablets ip 25 mg[282], clomiphene tablets ip 50 mg[283], calcium gluconate inj ip 10% (iv use) [388], concentrated solution forhaemodialysis b.p acetate concentrate in 10 litre cans. [399], peritonial dialysis solution ip [401], phenobarbitone inj ip 200mg/ml [420], hyaluronidase injection ip each vial contains hyaluronidase ip 1500 i.u. [423], aspirin gastro resistant tablets ip. each enteric coated tablet contains acetyl salicylic acid 75 mg [444], amlodipine and enalapril maleate tablets (amlodipine besilate equivalent to amlodipine 5 mg, enalapril maleate 5 mg) [457], timolol eye drops ip 0.5 o/o w/v [484], urokinase injection 5 lac unit (lyophilized) [557], betaxolol eye drops 0.5 o/o ip [612], terbutaline tablets ip 2.5 mg[619], mannitol with glycerin injection 10% +10% w/v (for intravenousinfusion) [632], an cl
ass="text-red-selected">vit
aminan> k-1 (phytomen
adione) ip 1mg/0.5ml injection (det
ail in rc) [644], concentr
ated solution for h
ameodi
alysis bp sodium hydrogen c
arbon
ate concentr
ate in 10 litre c
ans [687], t
ab l
amotrigine ip 50 mg (e
ach sust
ained rele
ase / prolonged rele
ase t
ablet cont
ains l
amotrigine ip 50 mg) [701], t
ab l
acos
amide 100 mg (e
ach film co
ated t
ablet cont
ains l
acos
amide 100 mg)[704], t
ab cyclophosph
amide ip 50 mg (e
ach sug
ar co
ated t
ablet cont
ains cyclophosph
amide ip53.5 mg equiv
alent to
anhydrous cyclophosph
amide 50 mg) [736], 3rd gener
ation recombin
ant f viii 250 iu with diluent [749], inj. esmolol hydrochloride 10mg/ml 10ml size [753], iron
and folic
acid t
ablets (if
a-red) e
ach sug
ar co
ated t
ablet sh
all cont
ain: dried ferrous sulph
ate ip 200 mg equiv
alent to- element
al ferrous iron - 60 mg folic
acid ip- 0.5mg, d
ac
arb
azine 200 mg inj. usp [nrd-21], isotretinoin 10mg c
ap. ip [nrd-26],
an class="text-red-selected">vitaminan>
a 25000 iu c
ap. ip [nrd-38],
amorolfine 0.25% cre
am [nrd-46], glycolic
acid 6% cre
am [nrd-51], hydroquinone 2% cre
am usp [nrd-53], di
ast
ase, pepsin with simethicone 15ml drope
ach ml cont
ains di
ast
ase (1:1200) 33.33mg, pepsin (1:3000) 5mg&
amp; simethicone emulsion 40mg [nrd-71], hydroxyzine hydrochloride or
al solution / drop 6mg/ml [nrd-76], ferrous
ascorb
ate
and folic
acid drops 15ml (e
ach ml cont
ains ferrous
ascorb
ate 10mg
and folic
acid 100mcg) [nrd-81],
an class="text-red-selected">vitaminan> e 50mg/ml drops 15ml [nrd-83], n
at
amycin opth
almic suspension 5% eye drop ip [nrd-94], ol
ap
at
adine 0.1%
and ketorol
ac 0.4% ophth
almic solution [nrd-95], hpmc 0.3% eye drop [nrd-104], chlor
amphenicol 1%, polymyxin b sulph
ate (10000 units)
and dex
ameth
asone 0.1% sodium phosph
ate eye ointment [nrd-123], progesterone injection 50 mg inj. bp [nrd-155], c
arfilzomib 60 mg inj. [nrd-174], c
armustine 100 mg inj. ip [nrd-175], cl
adr
abine 10 mg inj. [nrd-193], deg
arelix 120 mg inj. [nrd-210], detemir insuline 100iu/ml injection 3ml [nrd-214], flud
ar
abine phosph
ate injection 100mg inj. ip [nrd-237], flud
ar
abine phosph
ate injection 50mg inj. ip [nrd-238], folic
acid cynocob
al
amine
and nicotin
amide injection (e
ach ml cont
ains folic
acid 15mg/ml cynocob
al
amine 500 mcg/ml
and nicotin
amide 200 mg/ml) in 10 ml [nrd-241], horse
atg(
anti thymocyte globulin) 250 mg inj. [nrd-252], hp hmg (highly hum
an menop
aus
al p
arodied gon
adotropin) 150 iu inj. ip [nrd-253], insulin glulisine (monocomponent insulin glulisine) 100 iu/ml injection 3 ml [nrd-260], invert sug
ar injection ip 10% w/v [nrd-264], levosulpride 12.5 mg/mlinjection 2ml [nrd-274], inj. lignoc
aine (preserv
ative free) (e
ach ml cont
ains lignoc
aine ip 21.3 mg sodium chloride ip 6.0 mg 50 ml vi
al)[nrd-275], inj. methotrex
ate 250 mg (e
ach ml cont
ain methotrex
ate 25 mg in 10ml vi
al) [ nrd-288], methotrex
ate 1000 mg inj. ip [nrd-289], inj. methylprednisolone
acet
ate 125 mg i.p. (e
ach vi
al cont
ains methylprednisolone
acet
ate 125 mg) [nrd-2